SCHEMBL4461379

SCHEMBL4461379

CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)C(=O)CF)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 7/20 0.64
CASP7 P55210 5/20 0.64
CASP1 P29466 4/20 0.64
CASP9 P55211 4/20 0.64
CTSK P43235 5/20 0.56
CTSB P07858 2/20 0.56
CAPN1 P07384 1/20 0.51
CASP4 P49662 2/20 0.51
CASP10 Q92851 2/20 0.51
BACE1 P56817 2/20 0.51
BACE2 Q9Y5Z0 1/20 0.51
CASP5 P51878 1/20 0.51
CASP6 P55212 1/20 0.51
CASP8 Q14790 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2038936 0.96 CASP3 (0.69) CASP3CASP7CASP1CASP9CASP4
SCHEMBL7168373 0.95 CASP1 (0.58) CASP3CASP7CASP1CASP9CTSK
SCHEMBL15939366 0.92 CASP3 (0.64) CASP3CASP7CASP1CASP9CTSK
SCHEMBL29818103 0.92 CASP3 (0.64) CASP3CASP7CASP1CASP9CTSK
SCHEMBL2038060 0.89 CASP3 (0.63) CASP3CASP7CASP1CASP9CTSK
SCHEMBL2039051 0.87 CASP3 (0.69) CASP3CASP7CASP1CASP9CASP4
SCHEMBL4952116 0.87 CASP3 (0.60) CASP3CASP7CASP1CASP9CTSK
SCHEMBL2043662 0.86 CASP3 (0.56) CASP3CASP7CASP1CASP9CASP4
SCHEMBL29362585 0.85 CASP3 (0.76) CASP3CASP7CASP1CASP9CTSK
SCHEMBL2034855 0.84 CAPN1 (0.48) CASP3CASP7CASP1CASP9CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080808-A2 PHARMACEUTICAL FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) 2009-07-02 WO disclosed